BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2154988)

  • 1. Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex.
    Porter DJ; Harrington JA; Spector T
    Biochem Pharmacol; 1990 Feb; 39(4):639-46. PubMed ID: 2154988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).
    Spector T; Harrington JA; Porter DJ
    Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
    Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.
    Averett DR; Furman PA; Spector T
    J Virol; 1984 Dec; 52(3):981-3. PubMed ID: 6092726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme.
    Averett DR; Lubbers C; Elion GB; Spector T
    J Biol Chem; 1983 Aug; 258(16):9831-8. PubMed ID: 6309786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
    Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
    Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase.
    Blumenkopf TA; Harrington JA; Koble CS; Bankston DD; Morrison RW; Bigham EC; Styles VL; Spector T
    J Med Chem; 1992 Jun; 35(12):2306-14. PubMed ID: 1319497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice.
    Lobe DC; Spector T; Ellis MN
    Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
    Turk SR; Shipman C; Drach JC
    Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition.
    Spector T; Stonehuerner JG; Biron KK; Averett DR
    Biochem Pharmacol; 1987 Dec; 36(24):4341-6. PubMed ID: 2825724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
    Spector T; Jones TE
    J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir.
    Hamzeh FM; Spector T; Lietman PS
    Antimicrob Agents Chemother; 1993 Mar; 37(3):602-4. PubMed ID: 8384821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human ribonucleotide reductase. Activation and inhibition by analogs of ATP.
    Harrington JA; Spector T
    Biochem Pharmacol; 1991 Jul; 42(4):759-63. PubMed ID: 1867633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
    Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
    Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
    Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
    [No Abstract]   [Full Text] [Related]  

  • 16. Reductive inactivation of yeast glutathione reductase by Fe(II) and NADPH.
    Cardoso LA; Ferreira ST; Hermes-Lima M
    Comp Biochem Physiol A Mol Integr Physiol; 2008 Nov; 151(3):313-321. PubMed ID: 17544307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of deoxyadenosine triphosphate and 9-beta-D-arabinofuranosyl-adenine 5'-triphosphate on human ribonucleotide reductase from Molt-4F cells and the concept of "self-potentiation".
    Chang CH; Cheng YC
    Cancer Res; 1980 Oct; 40(10):3555-8. PubMed ID: 6159965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of ribonucleotide reductase from herpes simplex virus type 1. Evidence for 3' carbon-hydrogen bond cleavage and inactivation by nucleotide analogs.
    Ator MA; Stubbe J; Spector T
    J Biol Chem; 1986 Mar; 261(8):3595-9. PubMed ID: 3005293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins.
    Hodges YK; Antholine WE; Horwitz LD
    Biochem Biophys Res Commun; 2004 Mar; 315(3):595-8. PubMed ID: 14975742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.